LYRA - Lyra Therapeutics Quarterly EPS earnings growth

Official company branding of Lyra Therapeutics (LYRA)

The quarterly relative change in EPS demonstrates the profit dynamics of Lyra Therapeutics, Inc. (LYRA), where 0.00 shows the value of this parameter. The asset is resilient to market downturns, as development depends on internal commercialization milestones. Growth is driven by patents and Phase 3 trials of nasal systems. Supply chain efficiency guarantees sterility and precision in drug administration within clinics.

Lyra Therapeutics (LYRA) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 03/28/2026

Analytical breakdowns for Lyra Therapeutics, Inc.

- share price and expert price forecast:
Summary company analytics:Lyra Therapeutics Inc. - LYRA
Finished products of Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. (LYRA) is monetizing significant pricing power through its unique XTreo implant, which replaces long-term hormone therapy for the treatment of sinusitis. An analysis of the quarterly EPS growth index allows for tracking the net increase in share value, accounting for fiscal adjustments and subsidies, which helps investors assess the business's operational efficiency and the risks of capital freezing between financial reports.

Competitor analysis

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|AMPH (Amphastar) - Quarterly EPS earnings growth|Pacira Corp (PCRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|Quarterly EPS earnings growth Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic Therapeutic Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TNXP|SXTC (China SXT Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals (EPRX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences, Inc.|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORMP|ENTX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months MindWalk Holdings, Inc. HYFT|Quarterly EPS earnings growth abvcpharma.com ABVC|CPIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months QNTM|FGEN (FibroGen Corporation) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Telomir Pharma|Year-over-year net earnings per share growth for the last 12 months RANI|Earnings per share growth in annualized terms for the last twelve months synergychc.com SNYR|Year-over-year earnings per share growth for the last twelve months Rallybio Corp (RLYB)|LEXX - Earnings per share growth in annualized terms for the last twelve months|Pulmatrix Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PTHL|Aptorum Group Ltd - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)